Skip to main content
Equibles

Bernhardt Zeiher

Board Member

Entrada Therapeutics, Inc. (TRDA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Bernhardt Zeiher

Bernhardt Zeiher is recorded as Board Member at Entrada Therapeutics, Inc. (TRDA). Bernhardt Zeiher was last confirmed as Board Member at Amylyx Pharmaceuticals, Inc. (AMLX) in a filing dated April 24, 2025. Amylyx Pharmaceuticals, Inc. reported in an 8-K filed March 14, 2024 that Bernhardt Zeiher was appointed Class I director, effective March 14, 2024. Entrada Therapeutics, Inc. reported in an 8-K filed June 8, 2023 that Bernhardt Zeiher was appointed Class II director. Entrada Therapeutics, Inc. reported in an 8-K filed April 4, 2023 that Bernhardt Zeiher was appointed Class II director, effective April 4, 2023.

“On March 14, 2024 (the "Effective Date"), the Board of Directors (the "Board") of Amylyx Pharmaceuticals, Inc. (the "Company") appointed Bernhardt Zeiher, MD, FCCP, FACP to fill a vacancy on the Board as a Class I director for an initial term expiring at the annual meeting of stockholders in 2025.”
Amylyx Pharmaceuticals, Inc. Form 8-K, filed March 14, 2024 · Read the filing
“Peter S. Kim, Ph.D. and Bernhardt Zeiher, M.D. were duly elected to the Company's Board as Class II directors.”
Entrada Therapeutics, Inc. Form 8-K, filed June 8, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Entrada Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.